Healome Therapeutics

£2.0M seed

Announced: Jul 7, 2026
Sector: Ophthalmology/ocular drug delivery
Investors: 5

Summary

Healome Therapeutics closed an oversubscribed £2 million seed financing round led by Empirical Ventures. The proceeds will support pre-clinical development, manufacturing scale-up, regulatory engagement, and progress toward first-in-human studies expected in 2027.

Investors

Empirical Ventures, DEBRA Research, Cure EB, Oshen Bio, SFC Capital